波莫酸诱导非小细胞肺癌中铁质中介细胞死亡
Wenbin Ji1,2, Yanbin Zhang1,2, Wenhao Ji3
1The First Clinical Medical College, Ningxia Medical University, Yinchuan, Ningxia, China.
Frontiers in pharmacology
|June 19, 2025
概括
波莫酸 (PA) 通过诱导细胞死亡途径铁亡来对抗非小细胞肺癌 (NSCLC). 这项研究揭示了PA的分子机制,为新的NSCLC治疗提供了希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 波莫酸 (PA) 是一种来自Potentilla freyniana Bornm.的生物活性化合物.
- 在中国,PA显示为非小细胞肺癌 (NSCLC) 的息性使用.
- 在NSCLC中PA的疗效的分子机制尚未完全理解.
研究的目的:
- 在NSCLC中识别PA的核心分子标.
- 研究PA在NSCLC中的功能机制.
- 探索PA作为NSCLC治疗剂的潜力.
主要方法:
- 网络药理学被用来确定PA的目标.
- 试验室研究评估了PA对NSCLC细胞死亡和增殖的影响.
- 测量了铁灭的标志 (GSH 耗尽,脂质过氧化,ROS),蛋白质表达 (SLC40A1,SLC7A11,GPX4,ACSL4,HO-1) 和mRNA水平 (GPX4,SLC7A11,NRF2).这些标志包括:
主要成果:
- 帕显著抑制NSCLC细胞增殖和诱导细胞死亡.
- PA引发了铁亡,由GSH耗尽,脂质过氧化增加和ROS证明.
- 关键的铁灭调节体表现有变化:下调SLC40A1,SLC7A11,GPX4;上调ACSL4,HO-1;减少GPX4,SLC7A11,NRF2的mRNA水平.
结论:
- 通过诱导铁亡,PA在NSCLC中发挥抗癌作用.
- 与铁灭相关的蛋白质和基因的调制支持PA的作用机制.
- 作为一种潜在的治疗药物,PA在NSCLC治疗中表现有前途.
相关概念视频
Necrosis
4.9K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K


